The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients

Table 2

Comparisons of allelic frequencies of SLC22A1 rs594709 and SLC47A1 rs2289669 polymorphisms in T2DM patients and healthy subjects.

Genotype	T2DM patients; ()	Healthy controls; ()	value
SLC22A1 rs594709
AA	146 (54.68%)	95 (52.20%)	0.927
GA	99 (37.08%)	70 (38.46%)
GG	22 (8.24%)	17 (9.34%)
Alleles
A	391 (73.22%)	260 (71.43%)	0.555
G	143 (26.78%)	104 (28.57%)
SLC47A1 rs2289669
AA	77 (28.84%)	49 (26.92%)	0.669
GA	128 (47.94%)	95 (52.20%)
GG	62 (23.22%)	38 (20.88%)
Alleles
A	282 (52.81%)	193 (53.02%)	0.950
G	252 (47.19%)	171 (46.97%)